Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.

Tulsyan S, Chaturvedi P, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B.

Mol Diagn Ther. 2013 Dec;17(6):371-9. doi: 10.1007/s40291-013-0045-4.

PMID:
23812950
2.

Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.

Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S.

Urol Oncol. 2013 Oct;31(7):1193-203. doi: 10.1016/j.urolonc.2011.11.027. Epub 2011 Dec 11.

PMID:
22154357
3.

Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.

Ott K, Lordick F, Becker K, Ulm K, Siewert J, Höfler H, Keller G.

Int J Colorectal Dis. 2008 Aug;23(8):773-82. doi: 10.1007/s00384-008-0490-4. Epub 2008 Apr 29.

PMID:
18443805
4.

Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.

Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, Duan W, Huang M.

Eur J Pharm Sci. 2006 May;28(1-2):77-85. Epub 2006 Feb 20.

PMID:
16488119
5.

Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients.

Ji M, Tang J, Zhao J, Xu B, Qin J, Lu J.

Cancer Biol Ther. 2012 Mar;13(5):264-71. doi: 10.4161/cbt.18920. Epub 2012 Mar 1.

6.

GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, Coric V, Simic T.

Urol Oncol. 2013 Oct;31(7):1184-92. doi: 10.1016/j.urolonc.2011.08.005.

PMID:
24075358
7.

Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach.

Tulsyan S, Chaturvedi P, Singh AK, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B.

Gene. 2014 Jun 10;543(1):69-75. doi: 10.1016/j.gene.2014.04.004. Epub 2014 Apr 2.

PMID:
24704000
8.

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ.

J Natl Cancer Inst. 2002 Jun 19;94(12):936-42.

PMID:
12072547
9.

Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.

Funke S, Timofeeva M, Risch A, Hoffmeister M, Stegmaier C, Seiler CM, Brenner H, Chang-Claude J.

Pharmacogenomics. 2010 Jan;11(1):33-41. doi: 10.2217/pgs.09.132.

PMID:
20017670
10.

The association of glutathione-S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) with idiopathic male infertility.

Safarinejad MR, Shafiei N, Safarinejad S.

J Hum Genet. 2010 Sep;55(9):565-70. doi: 10.1038/jhg.2010.59. Epub 2010 May 27.

PMID:
20505681
11.

GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.

Oliveira AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, Longui CA, Melo MB.

Genet Mol Res. 2010 Jun 11;9(2):1045-53. doi: 10.4238/vol9-2gmr726.

12.

Impact of glutathione-S-transferase gene polymorphisms on enzyme activity, lung function and bronchial asthma susceptibility in Egyptian children.

Karam RA, Pasha HF, El-Shal AS, Rahman HM, Gad DM.

Gene. 2012 Apr 15;497(2):314-9. doi: 10.1016/j.gene.2012.01.059. Epub 2012 Feb 1.

PMID:
22326267
13.

Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India.

Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B.

Biomarkers. 2006 May-Jun;11(3):250-61.

PMID:
16760134
14.

Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.

García-González MA, Quintero E, Bujanda L, Nicolás D, Benito R, Strunk M, Santolaria S, Sopeña F, Badía M, Hijona E, Pérez-Aísa MA, Méndez-Sánchez IM, Thomson C, Carrera P, Piazuelo E, Jiménez P, Espinel J, Campo R, Manzano M, Geijo F, Pellisé M, González-Huix F, Espinós J, Titó L, Zaballa M, Pazo R, Lanas A.

Mutagenesis. 2012 Nov;27(6):771-7. doi: 10.1093/mutage/ges049. Epub 2012 Sep 5.

PMID:
22952149
15.

Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment.

Lakhdar R, Denden S, Knani J, Leban N, Daimi H, Hassine M, Lefranc G, Chibani JB, Khelil AH.

Dis Markers. 2011;30(5):253-63. doi: 10.3233/DMA-2011-0782.

16.

Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.

Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz JA, Moreno A, Román JM, Diaz-Rubio E, Caldés T.

Ann Oncol. 2012 Jul;23(7):1750-6. doi: 10.1093/annonc/mdr483. Epub 2011 Nov 2.

PMID:
22052985
17.

Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.

J Exp Ther Oncol. 2008;7(1):73-85.

PMID:
18472644
18.

TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.

Rajkumar T, Samson M, Rama R, Sridevi V, Mahji U, Swaminathan R, Nancy NK.

Breast Cancer Res Treat. 2008 Nov;112(1):81-7. Epub 2007 Dec 5.

PMID:
18058229
19.

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74.

20.

Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.

Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L.

Lung Cancer. 2008 Aug;61(2):152-62. doi: 10.1016/j.lungcan.2007.12.014. Epub 2008 Feb 14.

PMID:
18280004

Supplemental Content

Support Center